Russell Skibsted insider trades

Open-market stock purchases and sales by Russell Skibsted, Chief Financial Officer at Processa Pharmaceuticals, Inc, from SEC Form 4 filings since May 18, 2011.

Track record: 14% of 7 scored buys are up 5% or more since purchase, averaging +14%.

Recent trades

DateStockTradeValue
Jun 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.9K
May 29, 2026PCSA Processa Pharmaceuticals, IncBought$5.9K
May 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.9K
Apr 30, 2026PCSA Processa Pharmaceuticals, IncBought$5.9K
Apr 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.9K
Mar 31, 2026PCSA Processa Pharmaceuticals, IncBought$5.9K

Companies traded

  • PCSA Processa Pharmaceuticals, Inc: 6 buys, last Jun 15, 2026
  • ALIM Alimera Sciences Inc: other filings, last Nov 21, 2023
  • RMTI Rockwell Medical, Inc: other filings, last Sep 9, 2022
  • BTX Biotime Inc: 1 buy, last Dec 18, 2018
  • AOLS Aeolus Pharmaceuticals, Inc: 3 buys, last Mar 8, 2013

Get free alerts when Russell Skibsted files a new trade →